CANF
$0.90
Can-Fite Biopharma Ltd ADR
$.04
5.23%
CANF
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus: ($0.12)
Revenue: N/A
Share
Watch
Latest EPS
Thursday, May 26, 2022 at 7:00:00 AM ET
What do you expect when CANF reports earnings?
Where is CANF's stock price going from here?
Analysts
Description
Can Fite Biopharma Ltd. is a biopharmaceutical company. It is focused on developing drugs for the treatment of cancer and autoimmune inflammatory diseases. The Company's lead drug candidate, CF101, is in clinical development for the treatment of autoimmune inflammatory diseases. Its CF102 drug candidate is being developed for the treatment of liver diseases and its CF602 drug is being developed for the treatment of inflammation and sexual dysfunction. Can Fite Biopharma Ltd. is based in Petach Tikva, Israel.